Clarity Pharmaceuticals Ltd.ASX: CU6

50% recruitment reached for Phase II prostate cancer trial

Nov 2, 2022 at 3:30 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment